Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


COVID-19: Daily Top 10 Papers


  Vaccines

  Free Subscription


Articles published in Ann Intern Med

Retrieve available abstracts of 66 articles:
HTML format



Single Articles


    November 2021
  1. KUMAR D, Ferreira VH, Hall VG, Hu Q, et al
    Neutralization of SARS-CoV-2 Variants in Transplant Recipients After Two and Three Doses of mRNA-1273 Vaccine : Secondary Analysis of a Randomized Trial.
    Ann Intern Med. 2021 Nov 23. doi: 10.7326/M21-3480.
    PubMed     Abstract available


  2. CHO BH, Weinbaum C, Tsai Y, Koppaka R, et al
    Influenza Vaccine Uptake and Missed Opportunities Among the Medicare-Covered Population With High-Risk Conditions During the 2018 to 2019 Influenza Season : A Retrospective Cohort Study.
    Ann Intern Med. 2021 Nov 16. doi: 10.7326/M21-1550.
    PubMed     Abstract available


  3. SARPATWARI A, Pandya A, Hyle EP, Persad G, et al
    COVID-19 Vaccine Boosters for All Adults: An Optimal U.S. Approach?
    Ann Intern Med. 2021 Nov 9. doi: 10.7326/M21-3927.
    PubMed    


  4. MAKI DG
    Recommendations were made for diagnosis and management of allergic reactions to COVID-19 vaccines.
    Ann Intern Med. 2021 Nov 2. doi: 10.7326/ACPJ202111160.
    PubMed     Abstract available


  5. GRANWEHR BP
    BioNTech/Pfizer vaccine after Oxford/AZ vaccine increased immune response vs. no second vaccine.
    Ann Intern Med. 2021 Nov 2. doi: 10.7326/ACPJ202111160.
    PubMed     Abstract available


  6. SACKS HS
    The Novavax vaccine had 90% efficacy against COVID-19 >/=7 d after the second dose.
    Ann Intern Med. 2021 Nov 2. doi: 10.7326/ACPJ202111160.
    PubMed     Abstract available


  7. DORFMAN AL, Murthy VL
    Web Exclusive. Annals for Hospitalists Inpatient Notes - Myocarditis After Vaccination for SARS-CoV-2.
    Ann Intern Med. 2021;174:HO2-HO3.
    PubMed    


    October 2021
  8. NOVAZZI F, Taborelli S, Baj A, Focosi D, et al
    Asymptomatic SARS-CoV-2 Vaccine Breakthrough Infections in Health Care Workers Identified Through Routine Universal Surveillance Testing.
    Ann Intern Med. 2021 Oct 19. doi: 10.7326/M21-3486.
    PubMed    


  9. MELMED GY, Botwin GJ, Sobhani K, Li D, et al
    Antibody Responses After SARS-CoV-2 mRNA Vaccination in Adults With Inflammatory Bowel Disease.
    Ann Intern Med. 2021 Oct 12. doi: 10.7326/M21-2483.
    PubMed    


  10. DELANEY SW, Essien UR, Navathe A
    Disparate Impact: How Colorblind Policies Exacerbate Black-White Health Inequities.
    Ann Intern Med. 2021;174:1450-1451.
    PubMed    


    September 2021
  11. CURTIS JR, Cofield SS, Bridges SL Jr, Bassler J, et al
    The Safety and Immunologic Effectiveness of the Live Varicella-Zoster Vaccine in Patients Receiving Tumor Necrosis Factor Inhibitor Therapy : A Randomized Controlled Trial.
    Ann Intern Med. 2021 Sep 28. doi: 10.7326/M20-6928.
    PubMed     Abstract available


  12. AL-SAMKARI H, Leaf RK, Goodarzi K
    Transient Thrombocytopenia With Glycoprotein-Specific Platelet Autoantibodies After Ad26.COV2.S Vaccination: A Case Report.
    Ann Intern Med. 2021 Sep 14. doi: 10.7326/L21-0427.
    PubMed    


  13. MOGHADAS SM, Sah P, Shoukat A, Meyers LA, et al
    Population Immunity Against COVID-19 in the United States.
    Ann Intern Med. 2021 Sep 14. doi: 10.7326/M21-2721.
    PubMed     Abstract available


    August 2021
  14. DEEPAK P, Kim W, Paley MA, Yang M, et al
    Effect of Immunosuppression on the Immunogenicity of mRNA Vaccines to SARS-CoV-2 : A Prospective Cohort Study.
    Ann Intern Med. 2021 Aug 31. doi: 10.7326/M21-1757.
    PubMed     Abstract available


  15. PALTIEL AD, Schwartz JL
    Assessing COVID-19 Prevention Strategies to Permit the Safe Opening of Residential Colleges in Fall 2021.
    Ann Intern Med. 2021 Aug 31. doi: 10.7326/M21-2965.
    PubMed     Abstract available


  16. CENTOR RM, Klompas M, Pearson M, Morris C, et al
    Annals On Call - The Case for Mandating COVID-19 Vaccines for Health Care Workers.
    Ann Intern Med. 2021 Aug 10:OC1. doi: 10.7326/A20-0020.
    PubMed    


    July 2021
  17. EMANUEL EJ, Skorton DJ
    Mandating COVID-19 Vaccination for Health Care Workers.
    Ann Intern Med. 2021 Jul 30. doi: 10.7326/M21-3150.
    PubMed    


  18. BUTT AA, Omer SB, Yan P, Shaikh OS, et al
    SARS-CoV-2 Vaccine Effectiveness in a High-Risk National Population in a Real-World Setting.
    Ann Intern Med. 2021 Jul 20. doi: 10.7326/M21-1577.
    PubMed     Abstract available


  19. KLOMPAS M, Pearson M, Morris C
    The Case for Mandating COVID-19 Vaccines for Health Care Workers.
    Ann Intern Med. 2021 Jul 13. doi: 10.7326/M21-2366.
    PubMed    


  20. SACKS HS
    The single-dose J&J vaccine had 67% efficacy against moderate to severe-critical COVID-19 at >/=14 d.
    Ann Intern Med. 2021 Jul 6. doi: 10.7326/ACPJ202107200.
    PubMed     Abstract available


    June 2021
  21. SANGLI S, Virani A, Cheronis N, Vannatter B, et al
    Thrombosis With Thrombocytopenia After the Messenger RNA-1273 Vaccine.
    Ann Intern Med. 2021 Jun 29. doi: 10.7326/L21-0244.
    PubMed    


  22. LAVANGE L, Adam SJ, Currier JS, Higgs ES, et al
    Accelerating COVID-19 Therapeutic Interventions and Vaccines (ACTIV): Designing Master Protocols for Evaluation of Candidate COVID-19 Therapeutics.
    Ann Intern Med. 2021 Jun 29. doi: 10.7326/M21-1269.
    PubMed     Abstract available


  23. PISHKO AM, Cuker A
    Thrombosis After Vaccination With Messenger RNA-1273: Is This Vaccine-Induced Thrombosis and Thrombocytopenia or Thrombosis With Thrombocytopenia Syndrome?
    Ann Intern Med. 2021 Jun 29. doi: 10.7326/M21-2680.
    PubMed    


  24. THORNTON JD, Dixon-Williams S, Huml A, Perzynski A, et al
    A Cross-Sectional Study of SARS-CoV-2 Vaccination Among Employees of an Urban Safety-Net Health Care System.
    Ann Intern Med. 2021 Jun 15. doi: 10.7326/M21-1513.
    PubMed    


  25. MATHENY M, Maleque N, Channell N, Eisch AR, et al
    Severe Exacerbations of Systemic Capillary Leak Syndrome After COVID-19 Vaccination: A Case Series.
    Ann Intern Med. 2021 Jun 15. doi: 10.7326/L21-0250.
    PubMed    


  26. WERBEL WA, Boyarsky BJ, Ou MT, Massie AB, et al
    Safety and Immunogenicity of a Third Dose of SARS-CoV-2 Vaccine in Solid Organ Transplant Recipients: A Case Series.
    Ann Intern Med. 2021 Jun 15. doi: 10.7326/L21-0282.
    PubMed    


  27. BILINSKI A, Salomon JA, Giardina J, Ciaranello A, et al
    Passing the Test: A Model-Based Analysis of Safe School-Reopening Strategies.
    Ann Intern Med. 2021 Jun 8. doi: 10.7326/M21-0600.
    PubMed     Abstract available


    May 2021
  28. CONNOLLY CM, Boyarsky BJ, Ruddy JA, Werbel WA, et al
    Absence of Humoral Response After Two-Dose SARS-CoV-2 Messenger RNA Vaccination in Patients With Rheumatic and Musculoskeletal Diseases: A Case Series.
    Ann Intern Med. 2021 May 25. doi: 10.7326/M21-1451.
    PubMed    


  29. MARION O, Del Bello A, Abravanel F, Couat C, et al
    Safety and Immunogenicity of Anti-SARS-CoV-2 Messenger RNA Vaccines in Recipients of Solid Organ Transplants.
    Ann Intern Med. 2021 May 25. doi: 10.7326/M21-1341.
    PubMed    


  30. ARNOLD DT, Milne A, Samms E, Stadon L, et al
    Symptoms After COVID-19 Vaccination in Patients With Persistent Symptoms After Acute Infection: A Case Series.
    Ann Intern Med. 2021 May 25. doi: 10.7326/M21-1976.
    PubMed    


  31. IRFAN N, Chagla Z
    In South Africa, a 2-dose Oxford/AZ vaccine did not prevent mild to moderate COVID-19 (cases mainly B.1.351 variant).
    Ann Intern Med. 2021 May 4. doi: 10.7326/ACPJ202105180.
    PubMed     Abstract available


    April 2021

  32. Correction: Quantifying Potential Tradeoffs in COVID-19 Vaccine Deployment.
    Ann Intern Med. 2021 Apr 20. doi: 10.7326/L21-0233.
    PubMed    


  33. FOLLMANN D, Fintzi J, Fay MP, Janes HE, et al
    A Deferred-Vaccination Design to Assess Durability of COVID-19 Vaccine Effect After the Placebo Group Is Vaccinated.
    Ann Intern Med. 2021 Apr 13. doi: 10.7326/M20-8149.
    PubMed     Abstract available


  34. MUSTAFA SS, Ramsey A, Staicu ML
    Administration of a Second Dose of the Moderna COVID-19 Vaccine After an Immediate Hypersensitivity Reaction With the First Dose: Two Case Reports.
    Ann Intern Med. 2021 Apr 6. doi: 10.7326/L21-0104.
    PubMed    


    March 2021
  35. LAINE C, Cotton D, Moyer DV
    COVID-19 Vaccine: Practical Clinical Considerations.
    Ann Intern Med. 2021 Mar 26. doi: 10.7326/M21-1260.
    PubMed    


  36. TROGEN B, Caplan A
    Risk Compensation and COVID-19 Vaccines.
    Ann Intern Med. 2021 Mar 2. doi: 10.7326/M20-8251.
    PubMed    


  37. CHAGLA Z
    In high-risk adults, the Moderna vaccine had 94% efficacy against COVID-19 >/=14 d after the 2nd dose.
    Ann Intern Med. 2021 Mar 2. doi: 10.7326/ACPJ202103160.
    PubMed     Abstract available


  38. CHAGLA Z
    In adults, the Oxford/AstraZeneca vaccine had 70% efficacy against COVID-19 >14 d after the 2nd dose.
    Ann Intern Med. 2021 Mar 2. doi: 10.7326/ACPJ202103160.
    PubMed     Abstract available


  39. FREEDMAN MS, Bernstein H, Ault KA
    Recommended Adult Immunization Schedule, United States, 2021.
    Ann Intern Med. 2021;174:374-384.
    PubMed    


    February 2021
  40. CENTOR RM, Riley LE
    Annals On Call - Pregnancy, Lactation, and the COVID-19 Vaccines.
    Ann Intern Med. 2021 Feb 23:OC1. doi: 10.7326/A20-0009.
    PubMed    


  41. SALISCH NC, Stephenson KE, Williams K, Cox F, et al
    A Double-Blind, Randomized, Placebo-Controlled Phase 1 Study of Ad26.ZIKV.001, an Ad26-Vectored Anti-Zika Virus Vaccine.
    Ann Intern Med. 2021 Feb 16. doi: 10.7326/M20-5306.
    PubMed     Abstract available


  42. OPEL DJ, Lo B, Peek ME
    Addressing Mistrust About COVID-19 Vaccines Among Patients of Color.
    Ann Intern Med. 2021 Feb 9. doi: 10.7326/M21-0055.
    PubMed    


  43. GADOTH A, Halbrook M, Martin-Blais R, Gray A, et al
    Cross-sectional Assessment of COVID-19 Vaccine Acceptance Among Health Care Workers in Los Angeles.
    Ann Intern Med. 2021 Feb 9. doi: 10.7326/M20-7580.
    PubMed    


  44. TROTTER AB, Abbott EK, Coyle R, Shen AK, et al
    Preparing for COVID-19 Vaccination: A Call to Action for Clinicians on Immunization Information Systems.
    Ann Intern Med. 2021 Feb 2. doi: 10.7326/M20-7725.
    PubMed    


  45. CHAGLA Z
    The BNT162b2 (BioNTech/Pfizer) vaccine had 95% efficacy against COVID-19 >/=7 days after the 2nd dose.
    Ann Intern Med. 2021 Feb 2. doi: 10.7326/ACPJ202102160.
    PubMed     Abstract available


    January 2021
  46. RILEY LE, Jamieson DJ
    Inclusion of Pregnant and Lactating Persons in COVID-19 Vaccination Efforts.
    Ann Intern Med. 2021 Jan 26. doi: 10.7326/M21-0173.
    PubMed    


  47. FARRIS GE
    Annals Graphic Medicine - Dr. Mom: The Emotions of Getting the COVID-19 Vaccine.
    Ann Intern Med. 2021 Jan 26. doi: 10.7326/G20-0119.
    PubMed    


  48. GREGORY JM, Moore DJ
    The Dual Burden of Type 1 Diabetes and COVID-19.
    Ann Intern Med. 2021 Jan 26. doi: 10.7326/M21-0367.
    PubMed    


  49. LAINE C, Cotton D, Moyer DV
    COVID-19 Vaccine Distribution and Allocation: What Physicians Need to Know.
    Ann Intern Med. 2021 Jan 25. doi: 10.7326/M21-0331.
    PubMed    


  50. CONNORS M, Graham BS, Lane HC, Fauci AS, et al
    SARS-CoV-2 Vaccines: Much Accomplished, Much to Learn.
    Ann Intern Med. 2021 Jan 19. doi: 10.7326/M21-0111.
    PubMed    


  51. CENTOR RM, Manning KD
    Annals On Call - Vaccine Hesitancy: Choosing Our Battles.
    Ann Intern Med. 2021 Jan 19:OC1. doi: 10.7326/A20-0006.
    PubMed    


  52. PALTIEL AD, Zheng A, Schwartz JL
    Speed Versus Efficacy: Quantifying Potential Tradeoffs in COVID-19 Vaccine Deployment.
    Ann Intern Med. 2021 Jan 5. doi: 10.7326/M20-7866.
    PubMed    


  53. CARRERA M, Lawler EC, White C
    Population Mortality and Laws Encouraging Influenza Vaccination for Hospital Workers.
    Ann Intern Med. 2021 Jan 5. doi: 10.7326/M20-0413.
    PubMed     Abstract available


  54. BARNABAS RV, Wald A
    A Public Health COVID-19 Vaccination Strategy to Maximize the Health Gains for Every Single Vaccine Dose.
    Ann Intern Med. 2021 Jan 5. doi: 10.7326/M20-8060.
    PubMed    


  55. BOLLYKY TJ
    U.S. COVID-19 Vaccination Challenges Go Beyond Supply.
    Ann Intern Med. 2021 Jan 5. doi: 10.7326/M20-8280.
    PubMed    


  56. TUITE AR, Zhu L, Fisman DN, Salomon JA, et al
    Alternative Dose Allocation Strategies to Increase Benefits From Constrained COVID-19 Vaccine Supply.
    Ann Intern Med. 2021 Jan 5. doi: 10.7326/M20-8137.
    PubMed    


    December 2020
  57. LAINE C, Cotton D, Moyer DV
    COVID-19 Vaccine: Promoting Vaccine Acceptance.
    Ann Intern Med. 2020 Dec 21. doi: 10.7326/M20-8008.
    PubMed    


  58. PALMER T, Cuschieri K
    Human Papillomavirus Immunization and the Elimination of Cervical Carcinoma.
    Ann Intern Med. 2020;173:935-936.
    PubMed    


    November 2020
  59. CENTOR RM, Goepfert P
    Annals On Call - A Primer on COVID-19 Vaccines.
    Ann Intern Med. 2020 Nov 24:OC1. doi: 10.7326/A19-0044.
    PubMed    


  60. MACPHERSON A, Hutchinson N, Schneider O, Oliviero E, et al
    Probability of Success and Timelines for the Development of Vaccines for Emerging and Reemerged Viral Infectious Diseases.
    Ann Intern Med. 2020 Nov 24. doi: 10.7326/M20-5350.
    PubMed     Abstract available


  61. DAL-RE R, Caplan AL, Gluud C, Porcher R, et al
    Ethical and Scientific Considerations Regarding the Early Approval and Deployment of a COVID-19 Vaccine.
    Ann Intern Med. 2020 Nov 20. doi: 10.7326/M20-7357.
    PubMed    


    October 2020
  62. MEHROTRA DV, Janes HE, Fleming TR, Annunziato PW, et al
    Clinical Endpoints for Evaluating Efficacy in COVID-19 Vaccine Trials.
    Ann Intern Med. 2020 Oct 22. doi: 10.7326/M20-6169.
    PubMed     Abstract available


  63. LAINE C, Cotton D, Moyer DV
    COVID-19 Vaccine: What Physicians Need to Know.
    Ann Intern Med. 2020 Oct 20. doi: 10.7326/M20-6841.
    PubMed    


    September 2020
  64. BAUSSANO I, Tshomo U, Tenet V, Heideman DAM, et al
    Prevalence of Human Papillomavirus and Estimation of Human Papillomavirus Vaccine Effectiveness in Thimphu, Bhutan, in 2011-2012 and 2018 : A Cross-sectional Study.
    Ann Intern Med. 2020 Sep 22. doi: 10.7326/M20-2849.
    PubMed     Abstract available


  65. LUDVIGSSON JF, Winell H, Sandin S, Cnattingius S, et al
    Maternal Influenza A(H1N1) Immunization During Pregnancy and Risk for Autism Spectrum Disorder in Offspring : A Cohort Study.
    Ann Intern Med. 2020 Sep 1. doi: 10.7326/M20-0167.
    PubMed     Abstract available


    August 2020
  66. CHOW EJ, Rolfes MA, O'Halloran A, Anderson EJ, et al
    Acute Cardiovascular Events Associated With Influenza in Hospitalized Adults : A Cross-sectional Study.
    Ann Intern Med. 2020 Aug 25. doi: 10.7326/M20-1509.
    PubMed     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Vaccines is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: